Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients

Centre Hospitalier de Saint-Denis300 enrolled

Overview

This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Pneumonia, Ventilator-Associated Stenotrophomonas Maltophilia Intensive Care Units Anti-Bacterial Agents Drug Resistance, Bacterial

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients (age ≥ 18 years) * Hospitalized in Medical Intensive Care Unit between January 1, 2018, and December 31, 2023 * Intubated and mechanically ventilated * Diagnosed with ventilator-associated pneumonia caused by Stenotrophomonas maltophilia Exclusion Criteria: * Patients under 18 years old * Patients who refuse the use of their data for research purposes

Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients

Overview

Conditions

Eligibility

Locations (1)

Outcomes

Primary Outcomes